Cam Gallagher - Net Worth and Insider Trading
Cam Gallagher Net Worth
The estimated net worth of Cam Gallagher is at least $2 Million dollars as of 2024-12-28. Cam Gallagher is the President, Interim CFO of Zentalis Pharmaceuticals Inc and owns about 633,680 shares of Zentalis Pharmaceuticals Inc (ZNTL) stock worth over $2 Million. Details can be seen in Cam Gallagher's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cam Gallagher has not made any transactions after 2024-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cam Gallagher
Cam Gallagher Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cam Gallagher owns 3 companies in total, including Zentalis Pharmaceuticals Inc (ZNTL) , Sorrento Therapeutics Inc (SRNE) , and Opus Genetics Inc (IRD) .
Click here to see the complete history of Cam Gallagher’s form 4 insider trades.
Insider Ownership Summary of Cam Gallagher
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2024-05-31 | director |
| SRNE | Sorrento Therapeutics Inc | 2012-09-06 | director |
| IRD | Opus Genetics Inc | 2020-11-11 | director |
Cam Gallagher Latest Holdings Summary
Cam Gallagher currently owns a total of 1 stock. Cam Gallagher owns 633,680 shares of Zentalis Pharmaceuticals Inc (ZNTL) as of May 31, 2024, with a value of $2 Million.
Latest Holdings of Cam Gallagher
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals Inc | 2024-05-31 | 633,680 | 3.06 | 1,939,061 |
Holding Weightings of Cam Gallagher
Cam Gallagher Form 4 Trading Tracker
According to the SEC Form 4 filings, Cam Gallagher has made a total of 37 transactions in Zentalis Pharmaceuticals Inc (ZNTL) over the past 5 years, including 0 buys and 37 sells. The most-recent trade in Zentalis Pharmaceuticals Inc is the sale of 9,597 shares on May 31, 2024, which brought Cam Gallagher around $114,972.
Insider Trading History of Cam Gallagher
- 1
Cam Gallagher Trading Performance
Cam Gallagher Ownership Network
Cam Gallagher Owned Company Details
What does Zentalis Pharmaceuticals Inc do?
Who are the key executives at Zentalis Pharmaceuticals Inc?
Cam Gallagher is the director of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include Chief Financial Officer Melissa B, Epperly , General Counsel Andrea Paul , and Chief Medical Officer Carrie Brownstein .
Zentalis Pharmaceuticals Inc (ZNTL) Insider Trades Summary
Over the past 18 months, Cam Gallagher made 3 insider transaction in Zentalis Pharmaceuticals Inc (ZNTL) with a net sale of 22,322. Other recent insider transactions involving Zentalis Pharmaceuticals Inc (ZNTL) include a net sale of 16,724 shares made by Melissa B, Epperly , a net purchase of 17,000 shares made by David Michael Johnson , and a net sale of 10,628 shares made by Carrie Brownstein .
In summary, during the past 3 months, insiders sold 1,603 shares of Zentalis Pharmaceuticals Inc (ZNTL) in total and bought 0 shares, with a net sale of 1,603 shares. During the past 18 months, 70,596 shares of Zentalis Pharmaceuticals Inc (ZNTL) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 48,596 shares.
Zentalis Pharmaceuticals Inc (ZNTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zentalis Pharmaceuticals Inc Insider Transactions
Cam Gallagher Mailing Address
Above is the net worth, insider trading, and ownership report for Cam Gallagher. You might contact Cam Gallagher via mailing address: 6042 Cornerstone Ct. West, Suite B, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
